Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue:    
Product revenues $ 0 $ 0
License revenues 0 27,000
TOTAL NET REVENUE 0 27,000
Cost of Product Revenue 0 0
Gross profit 0 27,000
Operating Expenses:    
Research and development 975,000 1,000,000
Selling, general and administrative 8,399,000 7,954,000
Total operating expenses 9,374,000 8,954,000
Loss from Operations (9,374,000) (8,927,000)
Change in value of warrant and derivative liabilities 25,697,000 4,505,000
Interest expense/income (6,555,000) (17,039,000)
Total Other Income (Expense) 19,142,000 (12,534,000)
Loss before minority interest and provision for income taxes 9,768,000 (21,461,000)
Less: Net income attributable to the noncontrolling interests 0 0
Loss before provision for income taxes 9,768,000 (21,461,000)
Provision for income taxes 0 0
Net loss $ 9,768,000 $ (21,461,000)
Weighted Average Shares Outstanding Basic 24,427,906 2,394,540
Weighted Average Shares Outstanding Diluted 24,427,906 2,394,540
Net income (loss) per share Basic $ .40 $ (8.96)
Net income (loss) per share Diluted $ .40 $ (8.96)